Mayne Pharma Inc FDA Recalls

2 recalls on file across drugs, 0 of them Class I and 1 still open. This firm is not matched to a listed company.

Newest first

Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.

Product	Reason	Class	Initiated
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, ManufacClass IIJun 9, 2022Defective Delivery System: Out of specification for release	Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT st	Class IIDrugs	Jun 9, 2022
Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, Class IIJan 14, 2022CGMP Deviation: Difficulty dispensing/does not dispense or d	CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.	Class IIDrugs	Jan 14, 2022